The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies

被引:48
作者
Rasheed, ZA
Saleem, A
Ravee, Y
Pandolfi, PP
Rubin, EH
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA
[2] Univ Med & Dent New Jersey, Canc Inst New Jersey, New Brunswick, NJ USA
[3] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA
[4] Cornell Univ, Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA
关键词
D O I
10.1006/excr.2002.5550
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously identified topors as a topoisomerase I-binding protein that localizes in punctate nuclear regions when expressed as a GFP fusion protein. We now demonstrate that both the GFP-topors fusion protein and endogenous topors are associated with promyelocytic leukemia (PML) nuclear bodies in exponentially growing HeLa cells. Studies using isogenic PML+/+ and PML-/- murine embryonic fibroblasts indicate that the punctate nuclear localization of topors is dependent on PML. A basic C-terminal region but not the N-terminal RING domain of topors is required for the punctate nuclear localization of this protein. Additional studies indicate that topors, but not PML, rapidly relocalizes from nuclear bodies to the nucleoplasm in cells exposed to the transcription inhibitor dichloro-1-beta-D-ribofuranolsylbenzimidazole or to the topoisomerase I-targeting drug camptothecin. These results identify topors as a new member of the group of proteins that associate dynamically with PML nuclear bodies and suggest that topors may be involved in the cellular response to camptothecin. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:152 / 160
页数:9
相关论文
共 50 条
[41]   Interaction of U2AF(65) RS region with pre-mRNA of branch point and promotion base pairing with U2 snRNA [J].
Valcarcel, J ;
Gaur, RK ;
Singh, R ;
Green, MR .
SCIENCE, 1996, 273 (5282) :1706-1709
[42]   CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus [J].
von Mikecz, A ;
Zhang, SS ;
Montminy, M ;
Tan, EM ;
Hemmerich, P .
JOURNAL OF CELL BIOLOGY, 2000, 150 (01) :265-273
[43]   Characterization of topotecan-mediated redistribution of DNA topoisomerase I by digital imaging microscopy [J].
Wadkins, RM ;
Danks, MK ;
Horowitz, L ;
Baker, SD .
EXPERIMENTAL CELL RESEARCH, 1998, 241 (02) :332-339
[44]   DNA topoisomerases [J].
Wang, JC .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :635-692
[45]  
Wang ZG, 1998, SCIENCE, V279, P1547
[46]   The transcriptional role of PML and the nuclear body [J].
Zhong, S ;
Salomoni, P ;
Pandolfi, PP .
NATURE CELL BIOLOGY, 2000, 2 (05) :E85-E90
[47]   Role of SUMO-1-modified PML in nuclear body formation [J].
Zhong, S ;
Müller, S ;
Ronchetti, S ;
Freemont, PS ;
Dejean, A ;
Pandolfi, PP .
BLOOD, 2000, 95 (09) :2748-2753
[48]   Identification of a novel gene encoding a p53-associated protein [J].
Zhou, R ;
Wen, H ;
Ao, SZ .
GENE, 1999, 235 (1-2) :93-101
[49]   Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α (RARα) and oncogenic RARα fusion proteins [J].
Zhu, J ;
Gianni, M ;
Kopf, E ;
Honoré, N ;
Chelbi-Alix, M ;
Koken, M ;
Quignon, F ;
Rochette-Egly, C ;
de Thé, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :14807-14812
[50]   A role for PML and the nuclear body in genomic stability [J].
Zong, S ;
Hu, P ;
Ye, TZ ;
Stan, R ;
Ellis, NA ;
Pandolfi, PP .
ONCOGENE, 1999, 18 (56) :7941-7947